Testing a low-dose pneumonia vaccine with adjuvant
Treatments studied
Part of Immune system & allergy clinical trials.
This trial tests a new pneumonia vaccine to see if it is safe and helps the body fight off pneumonia. It uses a lower dose of the vaccine with a special ingredient to boost the immune response.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old.
- You are generally healthy.
- Your body mass index (BMI) is between 18.5 and 35.
- If you are a woman, you are not pregnant or breastfeeding and use effective birth control.
- You have not had a pneumonia infection in the last 3 years.
- You have not received a pneumonia vaccine in the last 3 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational vaccine that may protect infants against infections caused by a bacteria called Streptococcus pneumoniae, which can cause pneumonia and other serious illnesses. The vaccine is given to healthy babies around 2 months old, and the study will see how well it works and how safe it is.
This trial tests a new 23-valent pneumococcal vaccine to see if it safely protects healthy people against pneumonia and other infections caused by pneumococcal bacteria.
This study tests a new pneumococcal vaccine (PCV15) to see how well it protects against carrying the bacteria that can cause pneumonia. Healthy adults aged 18–50 who have not had a pneumococcal vaccine in the last 5 years may join.
This study tests a new pneumococcal vaccine (PCV24) for babies ages 2 to 23 months. It aims to see if the vaccine is safe and helps protect against serious infections like pneumonia and meningitis.
This study tests a new pneumonia vaccine (PCV13) in healthy infants to see if it works as well as a current vaccine. It compares the immune response and safety of the two vaccines.
This study tests a new vaccine that protects against 21 types of bacteria that cause pneumonia and other infections. It is for healthy infants around 2 months old to see if it works as well as the current vaccine.
Hear when a new Vaccine Reaction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.